2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with lariciresinol in 2 studies
| Studies (2,3-bis(3'-hydroxybenzyl)butyrolactone) | Trials (2,3-bis(3'-hydroxybenzyl)butyrolactone) | Recent Studies (post-2010) (2,3-bis(3'-hydroxybenzyl)butyrolactone) | Studies (lariciresinol) | Trials (lariciresinol) | Recent Studies (post-2010) (lariciresinol) |
|---|---|---|---|---|---|
| 319 | 32 | 124 | 77 | 0 | 43 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Airio, M; Dings, RP; Mäkelä, S; Saarinen, NM; Smeds, AI; Wärri, A | 1 |
| Debouche, C; During, A; Larondelle, Y; Raas, T | 1 |
2 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and lariciresinol
| Article | Year |
|---|---|
Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.
Topics: 4-Butyrolactone; 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Butylene Glycols; Carcinogens; Cell Proliferation; Dietary Supplements; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Furans; Gene Expression Regulation, Neoplastic; Humans; Lignans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Ovariectomy; Phytoestrogens; Rats; Receptors, Progesterone; Transplantation, Heterologous | 2008 |
Among plant lignans, pinoresinol has the strongest antiinflammatory properties in human intestinal Caco-2 cells.
Topics: 4-Butyrolactone; Anti-Inflammatory Agents; Butylene Glycols; Caco-2 Cells; Cell Differentiation; Chemokine CCL2; Chromatography, High Pressure Liquid; Cyclooxygenase 2; Furans; Glucosides; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; Intestines; Lignans; NF-kappa B; Plant Extracts; Signal Transduction | 2012 |